Cvb.Ax
CVB.AX operates in the healthcare equipment sector, providing medical devices and related technologies.
Business. CVB.AX operates in the healthcare equipment sector, providing medical devices and related technologies.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
CVB.AX operates in the healthcare equipment sector, providing medical devices and related technologies.
CVB.AX has a basic and diluted share count of 477,734,297, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
The company reported a negative EPS of -0.04 AUD and revenue of 12,097,000 AUD in the latest period, suggesting challenges in profitability and revenue generation. These figures fall below the industry median for profitability metrics, indicating underperformance relative to peers in the Advanced Medical Equipment & Technology industry.
CVB.AX's revenue concentration and geographic exposure are not disclosed in the available data, making it difficult to assess the company's risk from regional or segment-specific downturns.
The company's growth trajectory is unclear, as no forward-looking revenue guidance or historical growth rates are provided in the available data. This lack of data limits the ability to project future performance or assess the company's market position.
The risk assessment indicates low dilution potential, but liquidity risk remains unassessed due to missing balance-sheet data. No recent events, such as filings or transcripts, are available to provide additional context on the company's operations or strategic direction.
- CVB.AX has a basic and diluted share count of 477,734,297, indicating no immediate dilution pressure.
- The company reported a negative EPS of -0.04 AUD and revenue of 12,097,000 AUD, suggesting challenges in profitability and revenue generation.
- Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
- No recent events or forward-looking guidance are available to assess the company's strategic direction or growth trajectory.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- CVB.AX Market data — financials · 2026-05-27
- Curvebeam AI Ltd Market data — analyst estimates · 2026-05-27